Cargando…
Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia
Cannabis use disorder (CUD) occurs at high rates in schizophrenia, which negatively impacts its clinical prognosis. These patients have greater difficulty quitting cannabis which may reflect putative deficits in the dorsolateral prefrontal cortex (DLPFC), a potential target for treatment development...
Autores principales: | Bidzinski, Karolina Kozak, Lowe, Darby J. E., Sanches, Marcos, Sorkhou, Maryam, Boileau, Isabelle, Kiang, Michael, Blumberger, Daniel M., Remington, Gary, Ma, Clement, Castle, David J., Rabin, Rachel A., George, Tony P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873399/ https://www.ncbi.nlm.nih.gov/pubmed/35210458 http://dx.doi.org/10.1038/s41537-022-00210-6 |
Ejemplares similares
-
Neurocognitive moderation of repetitive transcranial magnetic stimulation (rTMS) effects on cannabis use in schizophrenia: a preliminary analysis
por: Johnstone, Samantha, et al.
Publicado: (2022) -
Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review
por: Johnstone, Samantha, et al.
Publicado: (2022) -
Neurobiological Determinants of Tobacco Smoking in Schizophrenia
por: Lucatch, Aliya M., et al.
Publicado: (2018) -
The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
por: Sorkhou, Maryam, et al.
Publicado: (2021) -
Contingency Management for Treatment of Cannabis Use Disorder in Co-Occurring Mental Health Disorders: A Systematic Review
por: Rodas, Justyne D., et al.
Publicado: (2022)